Doctors pioneer new area of cruelty free product development

December 12, 2005

Amid mounting concerns about the ethics and limitations of animal use in laboratories, the Physicians Committee for Responsible Medicine (PCRM) announced today that it has developed an animal serum free diagnostic test used to measure insulin levels in diabetes patients. Linco Research, Inc., a leading manufacturer of testing supplies based in St. Charles, Missouri, is now marketing the test internationally. The announcement of the new test comes just weeks after European Union officials and industry groups issued a joint declaration to reduce the use of animals in laboratories.

PCRM initiated development of the assay in 2002 after launching a clinical trial examining the effects of a low-fat vegan diet on diabetes. The only insulin test kits on the market at the time used two cruelly derived animal ingredients--fetal calf serum, a slaughterhouse byproduct that can harbor bacteria and viruses, and cells incubated in the abdomens of live mice, a painful procedure banned in several European countries but still legal in the United States. No one had ever manufactured an insulin assay kit without the animal serum, and numerous laboratories told PCRM it couldn't be done.

The resulting alternative, one grown in a synthetic medium, proved to be as accurate as the existing insulin testing method, and costs the same. Linco has begun manufacturing the animal-serum-free kit and offers it to researchers in the United States and abroad. The cruelty-free kit is expected to sell particularly well in Europe, where laboratories are concerned about bovine spongiform encephalopathy (mad cow disease) being transmitted in animal serum.

"Our success shows that a little ingenuity can do a lot to reduce the cruelty involved in medical testing," says Megha Even, M.S., the PCRM research analyst who headed up R&D on the assay. "If scientists put more effort into developing alternatives to the use of animals in medical research and testing, we could alleviate animal suffering and practice more effective medicine." Mrs. Even presented PCRM's insulin assay at the Fifth World Congress on Alternatives and Animal Use in the Life Sciences in Berlin and the Federation of American Societies for Experimental Biology earlier this year.
-end-
For an interview with Mrs. Even or further information, please contact Jeanne S. McVey at 202-686-2210, ext. 316, or jeannem@pcrm.org.

Founded in 1985, the Physicians Committee for Responsible Medicine is a nonprofit health organization that promotes preventive medicine, especially good nutrition. PCRM also conducts clinical research studies, opposes unethical human experimentation, and promotes alternatives to animal research.

Physicians Committee for Responsible Medicine

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.